EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies

Jiajie Zhang, Chenzhi Wang, Yanan Li, Zemeng Xiao, Zhenzhen Cai, Yuxuan Qian, Lei Shi, Qi Zhang

Ageing Research Reviews · 2026-07 · 119 · 103159

DOI: 10.1016/j.arr.2026.103159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-07. Verfasst von Jiajie Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Anesthesiology, Hebei Children's Hospital, Shijiazhuang…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Lipid Metabolism, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 317 Literaturangaben. Gefördert von: European Research Council, National Natural Science Foundation of China, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid homeostasis is essential for preserving the structural integrity and functional capacity of the brain. A diverse array of lipids, including cholesterol, phospholipids, and sphingolipids, has been identified as playing pivotal roles. Dysregulation of lipid metabolism is increasingly recognized as a central pathological mechanism in neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Huntington's Disease, and Cerebrotendinous Xanthomatosis, though much of the existing evidence comes from associative studies, and causal relationships still need to be further validated through interventional studies. Here we systematically review the metabolic pathways and regulatory networks of major brain lipids, with a focus on delineating disease-specific alterations and summarizing emerging therapeutic strategies targeting lipid metabolism. These strategies encompass the modulation of cholesterol homeostasis, sphingolipid metabolism, phospholipid signaling, and fatty acid oxidation, alongside approaches that enhance lipid clearance and neural repair. Preclinical advances and ongoing clinical trials underscore the translational potential of lipid-targeted interventions. In conclusion, we emphasize the potential of lipid metabolism as a promising avenue for developing novel treatments, offering insights to guide future research and therapeutic innovation in neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesLipid MetabolismBrainHumansAnimals

Stichwörter der Autor:innen

Alzheimer's diseaseLipid metabolismMitochondrial dysfunctionNeurodegenerationNeuroinflammationParkinson's disease

Autor:innen und Institutionen

  • Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Anesthesiology, Hebei Children's Hospital, Shijiazhuang, Hebei 050031, China.
  • Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei 050011, China.
  • Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.
  • Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • State Key Laboratory of Systems Medicine for Cancer, Department of Urology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China; Shanghai Key Laboratory o…
  • Department of Anesthesiology, Hebei Children's Hospital, Shijiazhuang, Hebei 050031, China; Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei 050031, China. Electronic address:…

Förderung

  • European Research Council
  • National Natural Science Foundation of China
  • Hebei Provincial Natural Science Foundation
  • HORIZON EUROPE Framework Programme

Zitieren

APA

Zhang, J., Wang, C., Li, Y., Xiao, Z., Cai, Z., Qian, Y., Shi, L., & Zhang, Q. (2026). Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies. Ageing Research Reviews, 119, 103159. https://doi.org/10.1016/j.arr.2026.103159

Vancouver

Zhang J, Wang C, Li Y, Xiao Z, Cai Z, Qian Y, et al. Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies. Ageing Research Reviews. 2026;119:103159. doi:10.1016/j.arr.2026.103159

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiajie and Wang, Chenzhi and Li, Yanan and Xiao, Zemeng and Cai, Zhenzhen and Qian, Yuxuan and Shi, Lei and Zhang, Qi},
  title = {Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {119},
  pages = {103159},
  doi = {10.1016/j.arr.2026.103159}
}
Kostenlos starten →